拉夏貝爾(06116.HK)上半年歸母淨虧損7.08億元
格隆匯 8 月 29日丨拉夏貝爾(06116.HK)發佈公告,受新冠肺炎疫情及公司關閉線下渠道經營網點、貨品採購量減少等因素影響,2020年上半年公司實現營業收入人民幣14.35億元,較上年同期營業收入人民幣39.51億元減少人民幣25.16億元,同比下降63.7%。由於往季品銷售佔比增加,公司整體毛利率下降至48.3%;由於疫情期間仍需承擔固定租賃支出及人員費用、關閉門店一次性確認攤銷費用、固定資產折舊增加等因素影響,公司銷售費用、管理費用下降幅度顯著小於收入降幅;綜上因素,2020年上半年公司實現歸屬於母公司股東的淨虧損為人民幣7.08億元,較上年同期虧損金額增加42.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.